Finn Patrick John 4

What Happened

• Finn Patrick John, President and COO of Twist Bioscience (TWST), reported the sale of 2,390 shares on 2026-01-23 at $44.91 per share, totaling approximately $107,330. The transaction is reported as a sale (code S) and was effected as a sell-to-cover to satisfy tax withholding on vested restricted stock units rather than a discretionary cash-sale.

Key Details

• Transaction date and price: 2026-01-23, 2,390 shares at $44.91 each.
• Total value: ~ $107,330.
• Shares owned after transaction: Not disclosed in the provided filing details.
• Footnote: The sale was mandated to cover tax withholding on RSU vesting (sell-to-cover), per the issuer's equity plan election (Footnote F1). This indicates the shares were sold to satisfy taxes, not necessarily a voluntary sell signal.
• Filing date vs. transaction date: Form filed 2026-01-27 reporting the 2026-01-23 transaction. Timeliness (late/on-time) is not flagged in the supplied data.

Context

• Sell-to-cover transactions are routine administrative sales to meet tax obligations when restricted stock units vest and generally do not alone indicate management sentiment about the company's outlook.
• For retail investors, note this is an insider sale tied to tax withholding rather than a discretionary liquidation; consider it lower informational value than voluntary open-market purchases.